This usage far exceeds NHS Englands initial goal of prescribing these drugs to 220,000 people over three years, explained lead author, Professor Sarah Jackson, from the UCL Institute of Epidemiology & Health Care
Water, Herbal Infusion (Indian gooseberry (Emblica officinalis) fruit*, Guduchi (Tinospora cordifolia) stem*, Lodhra (Symplocos racemosa) bark, Manjistha (Rubia cordifolia) stem*), Aloe (Aloe barbadensis) Leaf Juice, Glyceryl Stearate, Meadowfoam (Limnanthes alba) Seed Oil, Lactobacillus Ferment, Niacinamide, Cetearyl Alcohol, Cucumber (Cucumis sativus) Distillate*, Glycerin, Hemp seed (Cannabis sativa) oil*, Cetearyl Olivate, L-Carnitine, Olive (Olea europaea) Oil*, Sodium Hyaluronate, Vitamin E (non-GMO Tocopherols), Diaminopropionoyl Tripeptide-33 (Preventhelia), Acetyl Tetrapeptide-40 (Telangyn), Ceramide NP, Ceramide AP, Ceramide EOP, Phytosphingosine, Cholesterol, Sorbitan Olivate, Sodium Lauroyl Lactylate, Rosemary (Rosmarinus officinalis) Leaf Extract, Hydoxyethylcellulose, Carbomer, Caprylyl Glycol, Raspberry Ketone, Xanthan Gum, Citric Acid, Sodium Phytate, Potassium Sorbate, Sodium Bicarbonate
If unsure, consult a dermatologist
(CSE: SURE) (OTCQB: SURNF), (Profile) through its subsidiary GlucaPharm Inc., is advancing a differentiated next-generation GLP-1 platform centered on GEP-44, a novel triple agonist peptide designed to improve efficacy, tolerability and delivery flexibility in one of the fastest-growing pharmaceutical markets in history
